RESEARCHER PROFILE

A.N. Galustyan

← Back to Saint Petersburg State Pediatric Medical University

Saint Petersburg State Pediatric Medical University

Bacterial Infections and VaccinesPediatric health and respiratory diseasesAsthma and respiratory diseasesEpilepsy research and treatmentPneumonia and Respiratory Infections

A.N. Galustyan works in Bacterial Infections and Vaccines, Pediatric health and respiratory diseases, Asthma and respiratory diseases, Epilepsy research and treatment, Pneumonia and Respiratory Infections. Recorded institutional associations include Saint Petersburg State Pediatric Medical University.

79Publications

663Citations

8H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

← Return to the university profile

A.N. Galustyan

Saint Petersburg State Pediatric Medical University

Selected research works

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults

Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard

Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news

Differences in the standardization of medicinal products based on extracts of chondroitin sulfate

Comparative analysis of effectiveness and safety of phyto- and antibiotic therapy of acute bronchitis in children: results of a multicenter double blind randomized clinical trial

Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis

Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients

Third generation antiepileptic drugs: mechanism of action, pharmacokinetics, interaction and use in childhood

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

FRI0010 Pharmacokinetics, Safety and Tolerance of BCD-085, A Novel IL-17 Inhibitor, Based on The Results of Phase 1 Clinical Study in Healthy Volunteers

Palivizumab: Four Seasons in Russia

The use of tiotropium in basic therapy of bronchial asthma in children. Conclusion of the Expert Council of the Paediatric Respiratory Society

RELEASE-ACTIVE ANTIVIRAL DRUG ERGOFERON IN TREATMENT OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN. THE EFFICACY OF THE LIQUID DOSAGE FORM OF ERGOFERON: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL RESEARCH

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study

Impact of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms on antiepileptic drug safety and efficacy

[Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].

Systemic-biological analysis of synergic impact of progesterone, vitamins and trace elements on neuroprotection and fetal brain development

Immunological Efficacy and Safety of a New Pneumococcal Polysaccharide Conjugated Thirteen-Valent Vaccine in the Immunization of Adults and Children (Results of Clinical Studies in the Russian Federation)

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study

Su1160 A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy of 7 Days of Orally Administered Nepadutant in Infants With Colic - the NO-CRY Study

Contribution of prenatal factors and in formation of asthma phenotypes in children (part I)

О некоторых ролях калия и магния в терапевтической прак тике

Su1161 The Response Rate After Single and Repeated Doses of Nepadutant As Symptomatic Treatment of Infant Colic: the NO-CRY Phase II Clinical Trial